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A B S T R A C T
Objectives: Visceral leishmaniasis (VL) is a deadly disease endemic in all countries around
the Mediterranean Sea. In Palestine, VL is transmitted to humans from infected dogs by a sandﬂy
bite. The aim of this study was to investigate the epidemiology and spatiotemporal pattern of VL in
Palestine within a period of 27 years (1990–2017).
Methods: A long-term descriptive epidemiological study on human VL was conducted based on patient's
proﬁles to calculated disease prevalence, geographical, spatiotemporal and seasonal distribution,
distribution by age and gender, diagnosis, treatment, and treatment outcome.
Results: A total of 343 patients were reported, the average annual incidence rate was 0.73 case/100 000
population. Most cases came from the western parts of the West Bank. The number of reported males was
162 (51%), and patient’s age ranged from 4 months to 16 years (average 2.5 years), of which 93.3% were 5
years old. The annual incidence rate increased between 1993–1999, peaked in 1995, and dropped as from
2002. The future projections of VL indicate that the endemic foci in most governorates are projected to
disappear in the future and only the very northwest of the West Bank will be at risk of VL.
Conclusions: Visceral leishmaniasis continues to be endemic in the West Bank but not the Gaza Strip.
Pentavalent antimonial sodium stibogluconate continues to be the ﬁrst line treatment and physicians are
recommended to consider liposomal Amphotericin B (AmBisome) for refractory patients only.
Geographical, spatiotemporal and seasonal trends of VL were identiﬁed.
© 2019 The Author. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Leishmaniasis is a vector-borne disease caused by protozoan
parasites of the genus Leishmania and transmitted through the
bites of infected female phlebotomine sandﬂies. There are three
main forms of the disease; cutaneous, mucocutaneous and visceral
leishmaniasis (VL). The latter, also known as kala-azar, is the most
severe form and is fatal if not properly diagnosed and treated (Das
et al., 2016; WHO, 2019). VL is the second largest parasitic killer in
the world (after malaria), responsible for an estimated 0.7–1
million new cases and 26 000 to 65 000 deaths each year
worldwide (Desjeux, 2001; WHO, 2019). In Palestine, VL is
prevalent in the West Bank, mainly to western villages adjacent
to the Israeli VL endemic areas, with no cases reported from the
Gaza Strip (Amro et al., 2009a; Jaffe et al., 2004). The disease is
zoonotic and Leishmania infantum is the causative agent in both
humans and dogs (Amro et al., 2009a; Hamarsheh et al., 2012). TheE-mail addresses: ahmad.amro@staff.alquds.edu, ahmadymm@hotmail.com
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).latter has been identiﬁed as a VL reservoir in Palestine, found to be
infected with L. infantum in many endemic villages (Amro et al.,
2009a; Amro et al., 2009b; Jaffe et al., 2004). Human VL was
reported in infants and children, while adult cases were very rare
(Amro et al., 2009a). Moreover, VL-HIV coinfection has been
described in many countries around the Mediterranean Sea which
is uncommon in Palestine (Monge-Maillo et al., 2014). Several risk
factors associated with VL have been described. This includes
poverty, malnutrition, population displacement, having a dog or
other domestic animal, poor housing, weak immune system and
being a household member for a previously diagnosed VL case
(Amro et al., 2009a; WHO, 2019). Sandﬂy vectors have not been
thoroughly investigated in the Palestinian endemic villages.
Research studies have found numerous potential vectors abundant
in Jenin and Hebron governates. This includes Phlebotomus
syriacus, Ph. perﬁliewi, Ph. neglectus, and Ph. tobbi (Amro et al.,
2009a; Sawalha et al., 2003) which are proven vectors of L.
infantum in the Mediterranean region (Alten et al., 2016). However,
these studies were limited to a few endemic villages and a small
number of collected sandﬂies. Hence, the role of these species in
the transmission and distribution of VL in Palestine remains to be for Infectious Diseases. This is an open access article under the CC BY-NC-ND license
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aspirates and clinical picture characterized by hectic fever, weight
loss, hepatosplenomegaly, and anaemia. However, molecular and
serological methods for diagnosis and screening of VL have been
recently introduced (Amro et al., 2009a; Hamarsheh et al., 2012;
Nasereddin et al., 2009). Serological studies in Jenin and Hebron
revealed the presence of asymptomatic circulation of L. infantum
among local population. Seropositivity rates among healthy
children were 7.5% and 8.3% respectively (Amro et al., 2009a).
Moreover, seropositivity among apparently healthy dogs in the
West Bank ranged from 5.5% to 16.7 % (Abdeen et al., 2002;
Hamarsheh et al., 2012). However, no comprehensive study about
the prevalence and distribution of VL was done throughout
Palestine. The aim of this study is to investigate the epidemiology
of VL in Palestine during the period 1990 and 2017. This includes
disease prevalence in human population, geographical and
seasonal distribution, distribution by age and gender, diagnosis,
treatment, and determination of possible factors associated with
VL distribution and transmission. Moreover, spatial distribution of
Palestinian VL cases and projected future distributions are
explored based on climate change scenarios that could affect
and occurrence and density of the sandﬂy vectors in Palestine.
Materials and methods
Study design
We conducted a long-term descriptive epidemiological study
on human VL covering the 27-year period from 1990 to 2017 in
Palestine. The study was based on Palestinian Ministry of Health
(PMoH) records and collected patient proﬁles. This includes age,
gender, geographical origin, date of diagnosis, expected starting
date of infection for some cases, methods of diagnosis, treatment
regime and response. VL is a reportable disease in Palestine,
diagnosis and treatment is provided for free and exclusively by the
PMoH and its government hospitals. There was no change in
the reporting system over the time period, hence all cases of VL in
Palestine were included in this study.
Study area and population
Since no VL cases were reported from the Gaza Strip, we
investigated the PMoH reports in all areas in the West Bank. This
includes 11 governorates; Hebron, Beithlahem, Jerusalem, Ram-
allah, Jericho, Tubas, Salﬁt, Nablus, Qalqilya, Tulkarem, and Jenin
(Figure 1). The West Bank is located west of Jordan (Geographic
coordinates: 32 00 N, 35 15 E). It is 5640 km2 (including East
Jerusalem) and has a population of 2,856,691 inhabitants as
reported by the Palestinian Central Bureau of Statistics (PCBS) in
mid-2017 (PCBS, 2019). The population is distributed across 11
governorates and ranging from 70,5053 in Hebron to 49,568 in
Jericho (Figure 1).
The West Bank is characterized by great variation in its
topography and altitude (ranges from 400 below the sea level in
the Dead Sea area to 1020 m the highest point in Halhul, Hebron
governorate). The climate is mostly Mediterranean, slightly cooler
at elevated areas compared to the Dead Sea shoreline, which has a
dry and hot climate. The temperature and precipitation ﬂuctuate
according to altitude. They vary from warm to hot summers, and
cool to mild winters. Terrain is mostly rugged, dissected upland in
the west, and ﬂat plains descending to Jordan Valley to the east.
Data analysis
The average annual incidence rate per 100,000 population was
calculated for each governorate in the West Bank between1990–2017, based on mid-year population size estimated for each
governorate in the year of infection. Distribution and frequency
tables, ﬁgures and maps were plotted for each governorate, year
and month of infection, and average number of cases per year/
governorate. Moreover, cases were distributed by gender, age and
season of infection.
Spatiotemporal analysis and projections mapping
Correlative distribution modelling was performed with the
database of the Palestinian VL cases for the time period 1990–2017
as occurrence data. Conclusions were made based on these data
regarding the distribution of climatically suitable areas for VL
transmission based on sandﬂy biology.
A literature review was done to identify ecological and
environmental factors affecting sandﬂy distribution (Amro
et al., 2017; Bounoua et al., 2013; Boussaa et al., 2016); the
following eight of the 19 bioclimatic variables of Worldclim
(http://www.worldclim.org/bioclim) (Hijmans et al., 2005) were
selected for the current and future projections: BIO1 - Annual
Mean Temperature, BIO2 - Mean Diurnal Range (mean of monthly
(max temp–min temp)), BIO4 - Temperature Seasonality
(standard deviation *100), BIO7 - Temperature Annual Range
(BIO5-BIO6), BIO10 - Mean Temperature of Warmest Quarter,
BIO11 - Mean Temperature of Coldest Quarter, BIO12 - Annual
Precipitation, and BIO15 - Precipitation Seasonality (Coefﬁcient of
Variation). All climate data have spatial resolution of 2.5 arc-
minutes (approximately 5 km). The geographical location (longi-
tude, latitude) was obtained using GeoLocator (http://tools.
freeside.sk/geolocator/) (version 1.35).
Four modelling algorithms were applied to model the
distribution of VL: GLM (Generalized Linear Model) (Guisan
et al., 2002), GBM (Generalized Boosted Model) (Elith et al.,
2008) and RF (Random Forest) (Breiman, 2001) included in the
biomod2 R-Package version 3.3-7 (https://CRAN.R-project.org/
package=biomod2) (Thuiller et al., 2016) and MAXENT (Maxi-
mum-Entropy-Modelling) (Phillips et al., 2006). Ensemble model-
ling (Thuiller, 2003; Thuiller et al., 2009) was performed using
these four algorithms with each algorithm having the same
weighting (25 %). The available VL data from 1990-2017 were used
to calculate the current and the future projections (2041–2060) for
VL in Palestine. For future projections, the climate model mpi-esm-
lr (http://ccafs-climate.org/data_spatial_downscaling/) and the
emission scenario RCP 4.5 were used. RCP 4.5 is an intermediate
scenario expecting a raise in the global mean surface temperature
between 1.1 C and 2.6 C until the end of this century (Pachauri
et al., 2014). Mapping of the derived current and future projections
was done using GIS software (QGIS 2.8.4-Wien, http://www.qgis.
org/de/site/).
Ethics statement
All patient records and private data were anonymized and
handled conﬁdentially. The study protocol was revised and approved
by the Research Ethics Committee at Al-Quds University.
Results
Palestinian ministry of health reports and VL patient's proﬁles
were investigated for the period between 1990–2017. All cases
were reported exclusively from the West Bank with no cases
originated from The Gaza Strip. The total number of VL patients
reported in this period was 343 patients, the average annual
incidence rate was 0.73 case/100.000 population. No signiﬁcant
difference was reported between males and females. The number
of reported males was 162 (51%) and females 154 (49%). Male to
Figure 1. Distribution map of visceral leishmaniasis in Palestine between 1990 and 2017.
The geographic location of Gaza Strip and the West Bank, Palestine (top left). Distribution map of visceral leishmaniasis between 1990 and 2017 in each endemic governorate
in the West Bank with no cases originate from Gaza Strip. Cases are represented by the average number of patients per year, and in parenthesis the average annual incidence
rate per 100.000 population in each governorate. The table below shows the mid-year population for 2017 as estimated by the Palestinian Central Bureau of Statistics PCBS.
Maps were created, adapted and edited by Adobe1 Photoshop1 CC 2015 and Microsoft Paint (MSPaint) 2017.
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ranged from 4 months to 16 years (average 2.5 years). Only one
case from Jenin District aged 46 years was excluded from this
analysis. However, 93.3% of the patients were 5 years old or
younger.
Diagnosis was based on clinical symptoms, microscopic
examination of giemsa-stained smears of bone marrow aspirate
to conﬁrm the presence of Leishmania amastigotes, and patient’sresidency or travel to endemic areas. In 2011, molecular and
serological diagnostic approaches have been practically introduced
to the Central Public Health Laboratory of the PMoH. Patients were
treated successfully with intramuscular pentavalent antimonial
sodium stibogluconate (Pentostam1) solution containing 10% Sb5
+ (100 mg/ml) applying 10–20 mg Sb5 per kg body weight daily for
21 days. Treatment was given under supervision of medical
personnel in the PMoH hospitals. Treatment failure was observed
Table 1
Distribution of visceral leishmaniasis cases in the West Bank between 1990 and 2017.
Governorate Number of patientsa Percentage AAIR/105 populationb Average number of patients/years
Hebron 116 33.8% 1.00 6.82
Jenin 107 31.2% 2.17 7.13
Ramallah 45 13.1% 0.78 2.65
Tulkarem 38 11.1% 1.17 3.80
Nablus 12 3.5% 0.17 1.71
Salﬁt 8 2.3% 0.67 2.00
Tubas 6 1.7% 0.71 2.00
Qalqilya 6 1.7% 0.35 1.50
Beithlahem 3 0.9% 0.08 1.50
Jericho 2 0.6% 0.22 1.00
Total 343 100.0% 0.73 12.25
a Total number of patients between 1990 and 2017 in each endemic governorate.
b Average Annual Incidence Rate per 100.000 population calculated for each governorate.
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treatment and recovered after treatment with 0.25 mg/kg/day
liposomal amphotericin B (AmBisome).
The most endemic governorates were Jenin and Hebron, with a
total number of cases of 107 and 116 cases and an average annual
incidence rate of 2.17 and 1 cases/100.000, respectively. (Figure 1
and Table 1) show all governates in the West Bank with respective
distribution of VL cases represented by total and average number of
cases per year and average annual incidence rate/100.1000
population for the study period. 93.3% of the total cases came
from villages, compared to 6.7% who came from cities. The mostFigure 2. Annual and seasonal distribution of visceral leishmaniasis in Palestine betwe
(A): Distribution of VL patients per year. Data labels show the annual incidence rate/10
represented by the date of reporting as obtained from patient’s proﬁles (upper line), and 
cases) based on expectations given by patients or their parents.endemic villages in the West Bank were Beit Ula (27 cases), Idna
(14), Beit Awwa (11), Nuba (11), and Kharas (11) in the western part
of Hebron, and Yamoun and Jedideh in Jenin governorate with 28,
and 20 cases respectively.
Fluctuation in the incidence of VL over the studied period was
investigated. The annual incidence rate increased between 1993–
1999 and peaked in 1995. However, it has dropped dramatically
from 2000 onwards. No cases were reported during the years 2004,
2005 and 2008 (Figure 2A).
Monthly distribution was investigated to explore seasonality
trends of VL in Palestine. Higher incidence rates were reporteden 1990–2017.
0.000 population calculated for each year (B): Distribution of patients per month
expected dates of infection (lower line). The latter was provided for some cases (181
210 A. Ahmad / International Journal of Infectious Diseases 90 (2020) 206–212during the summer season (June–August) with the highest peak
recorded in June. However, the incidence rates decreased gradually
during autumn (September–November) to reach the lower level
during the winter season (December–February) and started a
gradual increase again in spring (March–May) (Figure 2B). For
some patients (181 cases), the infection date was provided
together with the reporting date. The average number of days
between infection and reporting dates for these patients was 36.1
(range 13–153 days). A similar pattern of seasonality was seen
when cases presented by dates of infection (Figure 2B).
Spatiotemporal analysis based on climatic conditions in
Palestine shows different climatic suitabilities for VL transmission
in different parts of the West Bank but not in the Gaza Strip.
This analysis included all VL conﬁrmed cases reported by
Palestinian Ministry of Health for the period between 1990–2017.
Figure 3 shows the present and potential future climatic
suitabilities for VL cases for this period. The future projection
was calculated for the years 2041-2060. The number of cases in
each endemic area was added to the presence projection and
indicated as different symbols in the map.
Discussion
The epidemiology and distribution of VL in Palestine over a 27-
year period was investigated. A total of 343 patients were reported,
of whom 93.3% were 5 years old or younger. VL in Palestine is
predominant in young children. This is similar to the disease
pattern of infantile Mediterranean Kala-azar where 95% of theFigure 3. Spatiotemporal analysis of VL in Palestine.
Spatiotemporal analysis of the Palestinian (VL) of the time period 1990–2017. Modelled c
the presence (left map) and the future (right map) are shown. Future projection of VL in P
and the RCP 4.5 scenario. Number of (VL) cases in each area were added to the presence p
the number of VL cases in the different regions of the country.cases are under 5 years (Aissi et al., 2015; Amro et al., 2009a). A
number of studies related this pattern to the immaturity of the
immune system, malnutrition in childhood and to the afﬁnity of
sandﬂy to this group (Dedet, 2001). Gender-related differences in
VL occurrence were not signiﬁcant. The trend of equal gender ratio
remains the same throughout the study period and was consistent
with other studies (Amro et al., 2009a). This indicates equal
exposure of children (5 years) to the sandﬂy and same pattern of
disease prognosis since differences at this age are not signiﬁcantly
apparent.
VL diagnosis was based on clinical signs and symptoms, direct
microscopy of splenic or bone marrow aspirates, and patient’s
history of residency in or travel to endemic areas. These
approaches might not be speciﬁc enough to differentiate the
condition from other systemic infections. Introduction of molecu-
lar and serological diagnostic approaches by applying the ITS1 PCR-
RFLP (Schonian et al., 2003) and ELISA test (Baneth et al., 1998)
respectively, contributed considerably to improved sensitivity and
speciﬁcity of detecting VL patients, and consequently better
disease outcome and surveillance (Health Mo, 2017). Patients in
Palestine are successfully treated with the ﬁrst line treatment of VL
(Pentostam1). However, treatment failure was reported in 2005 of
two cases who recovered after being treated with liposomal
Amphotericin B (AmBisome) (Amro et al., 2009a). Such treatment
failure is not common in the Mediterranean region where
pentavalent antimonials continue to be effective, and is more
common in India and Nepal (Sundar and Chakravarty, 2015).
Consequently, physicians are recommended to keep pentavalenturrent and future climatic suitabilities for VL are shown on the maps. Projections for
alestine was calculated for the years 2041–2060 using the mpi-esm-lr climate model
rojections (indicated as different symbols in the map), showing the occurrence and
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Palestine and considering the liposomal Amphotericin B (AmBi-
some), available as antifungal agent by the PMoH, for refractory
patients only.
The areas with the highest climatic suitabilities for VL in the
presence are found in the western part of the West Bank. These
areas represent an extension line from Jenin in the north to Hebron
in the south along the West Bank and bordering the Israeli VL foci
(Abdeen et al., 2002; Amro et al., 2009a; Jaffe et al., 2004) which
were opened to each other until their recent separation by the
Israeli wall. Generally, there is high risk of VL occurrence due to
climatic suitability for the vectors along villages in these areas.
These villages have similar ecology, altitude, topography, soil and
cultivation activities which differ from those in the Jordan Valley
and The Gaza Strip. These conditions can interfere with the sandﬂy
population and activity, and consequently with VL incidence
(Peterson and Shaw, 2003; Rotureau et al., 2006; Wasserberg et al.,
2002). Other risk factors have been described in these villages,
including a high number of stray and domestic dogs, low
socioeconomic level, and the presence of many uncontrolled
dumping sites (Abdeen et al., 2002; Amro et al., 2009a).
The number of VL patients increased between 1993–1999 and
peaked in 1995. According to previous reports (Amro et al.,
2009b), most of the VL cases reported during this period came
mainly from recently constructed housing built during the
massive expansion of these villages, following the Oslo Agree-
ment between the Palestinians and Israel. This construction is at
the periphery of villages and closer to the Israeli endemic areas
where sandﬂies and stray dogs were abundant (Amro et al.,
2009b). However, VL disappeared from the adjacent Israeli
endemic areas during the period 1950–1994 (Jaffe et al., 2004)
and re-emerged in 1994–1995 (the Palestinian peak) when an
Israeli child and ﬁve dogs were diagnosed with VL (Baneth et al.,
1998). From 2002 onward, the number of patients dropped
dramatically and VL become hypo endemic in Palestine. This
might be due to increased public awareness of the disease, and
application of control measures such as spraying of insecticides in
and around residences of VL patients and elimination of infected
and stray dogs, which have led to better disease surveillance.
Conversely, incidence of cutaneous leishmaniasis remains high
especially in Jericho and the neighbouring areas in the Jordan
Valley (Al-Jawabreh et al., 2017).
The future projections of VL indicate that the endemic foci in
most governorates are projected to disappear in the future and
only the very northwest of the West Bank will be at risk of VL.
These projections based on climatic conditions showed that
Hebron, Beithlahem, Jerusalem, Ramallah, Jericho, Tubas, Salﬁt and
Nablus governorates are projected to offer less favourable
conditions for vectors transmitting VL compared to Qalqilya,
Tulkarem, and Jenin in the northwest which are at a higher level of
risk. A decreasing suitability for VL can be expected in Palestine
because of the projected climate changes with respect to the
included bioclimatic variables. These changes include a decrease of
the humidity and an increase of the temperature to a level that
cannot be tolerated by VL transmitting vectors. These conditions
are vital for survival, development, behaviour and activity of
sandﬂies (Kasap and Alten, 2005). However, our results might have
some drawbacks including lack of information about sandﬂy
population density and conﬁrmed transmitting vectors of VL in
Palestine, lack of coordinates precision for each VL case, changing
weather conditions year by year since our maps were done using
the mean value of bio climatic variables over several years, and all
bio climatic variables have only a mean value of the year and are
not available for each season (winter, spring, summer and
autumn).The difference between infection dates and reporting dates of
VL in Palestine ranged from 13 to 153 days (2 weeks–4 Months).
This period is in agreement with the established incubation period
of VL published in many endemic countries (Miro and Lopez-Velez,
2018).VL infections occur seasonally in parallel with sandﬂy vector
abundance in Palestine, which increases from Jun to October and
peaked in August (Sawalha et al., 2003). Investigation of sandﬂy
fauna in Jenin and Hebron governorates revealed the abundance of
three putative vector species transmitting VL, Ph. perﬁliewi, Ph.
syriacus and Ph. Tobbi. However, the sandﬂy distribution differs in
the two governorates, where Ph. perﬁliewi was most abundant in
Jenin followed by Ph. tobbi and Ph. (L.). syriacus which were most
abundant in Hebron governorate (Amro et al., 2009a; Sawalha
et al., 2003). These differences might be due to signiﬁcant
variations in climatic parameters between Hebron and Jenin
governorates, where the altitude ranges from (600–1011 m) and
(300–500 m) respectively. However, the dynamic of sandﬂy fauna
and its relation to the seasonal and geographical distribution of VL
cases in Palestine is not well established and has to be thoroughly
investigated.
In conclusion, visceral leishmaniasis continues to be endemic in
the West Bank but not the Gaza Strip. The disease was shown to
follow the epidemiological pattern of zoonotic infantile disease
characteristic for the Mediterranean countries. L. infantum
is the causative agent and dogs are conﬁrmed reservoirs. However,
the transmitting sandﬂy vector has not been yet conﬁrmed.
Introduction of modern molecular and serological diagnostic
methods contributed necessarily to better diagnosis and outcome
of the disease. Pentavalent antimonial sodium stibogluconate
continues to be the ﬁrst line treatment and physicians are
recommended to consider liposomal Amphotericin B (AmBisome)
for refractory patients only. Geographical and seasonal trends of VL
were identiﬁed. This can help in implementing effective control
programs to reduce disease transmission.
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